IBM announced yesterday that they have signed a $1.4 billion, seven-year global strategic outsourcing agreement with AstraZeneca.The agreement renews and expands on the scope of an existing contract and covers the provision of IT infrastructure services to 60 countries. It includes services to additional functions within AstraZeneca, one of the world's largest pharmaceutical companies.
About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4 Good Index.
Details
No comments:
Post a Comment
Comments posted on i-Stuff are moderated and will be approved only if they are found on-topic and not abusive. Off-topic comments and URL Promotions are not encouraged and will not be entertained - Kevin